Perry, T. A. https://orcid.org/0000-0002-0499-3033
Deng, Y.
Hulley, P. A. https://orcid.org/0000-0002-4994-2264
Maciewicz, R. A. https://orcid.org/0000-0002-5371-7828
Mitchelmore, J.
Larsson, S. https://orcid.org/0000-0001-8626-9892
Gogain, J. https://orcid.org/0000-0001-7748-4822
Brachat, S.
Struglics, A. https://orcid.org/0000-0003-4289-1393
Appleton, C. T. https://orcid.org/0000-0001-7148-0767
Kluzek, S. https://orcid.org/0000-0002-0696-7541
Arden, N. K. https://orcid.org/0000-0002-3452-3382
Felson, D. https://orcid.org/0000-0002-2668-2447
Bondi, L. https://orcid.org/0000-0002-7034-9406
Kapoor, M. https://orcid.org/0000-0001-7994-110X
Lohmander, L. S. https://orcid.org/0000-0002-5424-9448
Welting, T. J. https://orcid.org/0000-0001-8081-4466
Walsh, D. A. https://orcid.org/0000-0002-6316-5692
Valdes, A. M. https://orcid.org/0000-0003-1141-4471
Jostins-Dean, Luke https://orcid.org/0000-0002-2475-3969
Watt, Fiona E. https://orcid.org/0000-0002-6066-7590
Tom, B. D. M. https://orcid.org/0000-0002-3335-9322
Vincent, T. L. https://orcid.org/0000-0001-9594-7085
,
,
Perry, Thomas A.
Deng, Yun
Hulley, Philippa A.
Maciewicz, Rose M.
Kluzek, Stefan
Arden, Nigel K.
Vincent, Tonia L.
Batchelor, Vicky
Mackay-Alderson, Jennifer
Brewer, Gretchen
Marsden, Brian
Price, Andrew J.
Goff, Megan
Kumar, Vinod
Tey, James
Szommer, Tamas
,
Mitchelmore, Joanna
Brachat, Sophie
Gasser, Juerg
Jennings, Lori
,
Larsson, Staffan
Struglics, André
Lohmander, L. Stefan
,
Gogain, Joe
Perry, Darryl
Mitchel, Anna
Zepko, Ela
,
Appleton, C. Thomas
Birmingham, Trevor B.
Klapak, J. Daniel
,
Felson, David
,
Bondi, Laura
Tom, Brian D. M.
,
Kapoor, Mohit
Gandhi, Rajiv
Perruccio, Anthony
Rampersaud, Y. Raja
Perry, Kim
,
Welting, Tim J.
Emans, Pieter
Boymans, Tim
Jutten, Liesbeth
Caron, Marjolein
Akker, Guus van den
,
Walsh, David A.
Valdes, Ana M.
Doherty, Michael
Georgopoulos, Vasileios
,
Papadaki, Artemis
,
Williams, Andrew
,
Hardingham, Tim
,
Kennedy, Sarah
Tambiah, Jeymi
,
Galesso, Devis
Giordan, Nicola
,
Ali, Waqar
Article History
Received: 5 June 2025
Accepted: 11 March 2026
First Online: 2 June 2026
Competing interests
: TAP, YD, PAH, SL, AS, NKA, DF, MK, AMV, BDMT, LB and SK declare no conflicts of interest. FEW has received consultancy fees from Pfizer and Novartis. LSL has received consultancy fees from Arthro Therapeutics AB, and was an advisory board member of AstraZeneca. LJD has received consultancy fees from Nightingale Health PLC. TLV has no conflicts to declare with the exception of grant income for STEpUP OA from industry partners (see above). RAM is a shareholder of AstraZeneca. SB and JM are employees and shareholders of Novartis. JG is an employee and shareholder of Standard BioTools (formally SomaLogic). CTA has received consultancy fees from Novartis, and has received honoraria for educational purposes also from Novartis. TJW is a shareholder of Chondropeptix BV. DAW has received consultancy fees from GlaxoSmithKline plc, AKL Research & Development Limited, Pfizer Ltd, Eli Lilly and Company, Contura International, and AbbVie Inc, has received honoraria for educational purposes from Pfizer Ltd and AbbVie Inc, is a board member (Director) of UKRI and Versus Arthritis Advanced Pain Discovery Platform. The authors declare no other competing interests.